BMC Medical Co Ltd
SZSE:301367
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
BMC Medical Co Ltd's latest stock split occurred on May 29, 2024
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, BMC Medical Co Ltd traded at 81.16 per share. Afterward, the share price was about 57.49.
The adjusted shares began trading on May 29, 2024. This was the only stock split in BMC Medical Co Ltd's history.
Global
Stock Splits Monitor
| Date | Company | Split | Pre-Split Price | Post-Split Price | |
|---|---|---|---|---|---|
|
Apr 27, 2026
|
M
|
Mitsubishi Logisnext Co Ltd
TSE:7105
|
1-for-22962728
/22962728
|
1529 999999.9999 JPY | N/A |
|
Apr 27, 2026
|
|
Intsig Information Co Ltd
SSE:688615
|
1-for-1
x1
|
180.14 127.0214 CNY | 128 128 CNY |
|
Apr 27, 2026
|
|
Nousouken Corp
TSE:3541
|
1-for-550000
/550000
|
763 763 JPY | N/A |
|
Apr 27, 2026
|
F
|
Friendly Corp
TSE:8209
|
1-for-1355800
/1355800
|
312 999999.9999 JPY | N/A |
|
Apr 27, 2026
|
I
|
IA Inc
KOSDAQ:038880
|
1-for-10
/10
|
135 1350 KRW | 1231 1231 KRW |
688615
3541
BMC Medical Co Ltd
Glance View
BMC Medical Co. Ltd. principally engages in the research, development, production, and sale of medical equipment and consumable products in the field of respiratory health. The company is headquartered in Beijing, Beijing and currently employs 843 full-time employees. The company went IPO on 2022-11-01. The firm's products mainly include non-invasive home ventilators, ventilation masks, sleep monitors and high-flow humidified oxygen therapy devices. The firm also provides respiratory health chronic disease management services. The firm focuses on the treatment of patients with sleep apnea-hypopnea syndrome (SAHS), mainly obstructive sleep apnea syndrome (OSA), as well as patients with respiratory insufficiency, mainly chronic obstructive pulmonary disease (COPD), providing a full-cycle and multi-scenario overall solution for treatment services.
